Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Given Consensus Rating of “Moderate Buy” by Brokerages

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has received a consensus recommendation of “Moderate Buy” from the ten research firms that are currently covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $75.44.

ACHC has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and increased their target price for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. Cantor Fitzgerald restated a “neutral” rating and issued a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Barclays cut their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research note on Friday, November 22nd. StockNews.com upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Thursday, December 19th. Finally, KeyCorp started coverage on shares of Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating for the company.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in ACHC. GAMMA Investing LLC boosted its position in Acadia Healthcare by 57.1% during the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after acquiring an additional 241 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in Acadia Healthcare in the second quarter valued at about $59,000. Covestor Ltd grew its stake in Acadia Healthcare by 834.4% during the third quarter. Covestor Ltd now owns 1,140 shares of the company’s stock worth $72,000 after buying an additional 1,018 shares in the last quarter. DekaBank Deutsche Girozentrale bought a new position in Acadia Healthcare in the 3rd quarter valued at about $86,000. Finally, nVerses Capital LLC acquired a new position in shares of Acadia Healthcare in the 2nd quarter valued at approximately $95,000.

Acadia Healthcare Stock Up 1.1 %

Shares of Acadia Healthcare stock opened at $38.07 on Friday. Acadia Healthcare has a 12-month low of $36.50 and a 12-month high of $87.77. The stock has a market capitalization of $3.54 billion, a P/E ratio of 12.48, a PEG ratio of 1.77 and a beta of 1.30. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock has a 50 day moving average price of $42.21 and a two-hundred day moving average price of $59.96.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. During the same period last year, the business posted $0.91 EPS. Acadia Healthcare’s revenue was up 8.7% compared to the same quarter last year. Equities analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.